The field of gene editing recently got a major boost from Massachusetts-based Beam Therapeutics, and the company’s Durham ...

StockNews.com initiated coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research note published ...

GreenLight Biosciences, Inc., a Boston-based agtech company with lab, office and greenhouse space in RTP, has closed a Series C funding round, including a $25 million investment from a new investor, ...

High Point Clinical Trials emptied and padlocked its building in 2023 after being sued several times in the months before.

Good morning, ladies and gentlemen, and welcome to the LENZ Therapeutics Year End 2024 Financial ... by commercial launch activities in the United States, with products anticipated to be available ...

Alan H. Bryce, MD, discusses areas of need to help guide treatment decisions in the clinic for prostate cancer management.

In the past 60 days, estimates for CytomX Therapeutics’ have moved from a loss of 31 cents per share to earnings of 25 cents ...

United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...

United Therapeutics (UTHR) announced that ten posters and presentations across its commercial and development portfolio will be presented at ...

3 Reasons Investors Watch United Therapeutics (UTHR) Over the last six months, United Therapeutics shares have sunk to $308.27, producing a disappointing 14% loss - worse than the S&P 500’s 1.4% ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 02, 2025--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Great Place ...